When and why placebo-prescribing is acceptable and unacceptable: a focus group study of patients' views. [PDF]
PLoS ONE, 2014 Surveys of doctors suggest that they use placebos and placebo effects clinically to help patients. However, patients' views are not well-understood.
Felicity L Bishop +2 more
doaj +1 more source
Teoría de la complejidad en la atención del paciente con dolor musculoesquelético
Biomédica: revista del Instituto Nacional de Salud, 2022 Los sistemas no lineales no son susceptibles de ser investigados con métodos reduccionistas. En este sentido, la teoría de la complejidad ofrece un enfoque alternativo para cuantificar la importancia de los factores contextuales en el paciente con dolor ...
Mauro Andreu +3 more
doaj +1 more source
Placebos and Medical Education
McGill Journal of Medicine, 2020 N ...
Amir Raz, Daniella Guindi
doaj +1 more source
When a placebo is not a ‘placebo’: a placebo effect on postprandial glycaemia [PDF]
British Journal of Clinical Pharmacology, 2007 What is already known about this subject • Although placebo effects have been shown on subjective continuous variables such as pain, placebo effects on objective continuous variables remain uncertain.• The present, pilot, follow‐up investigation represents the first to assess a placebo effect on the objective continuous measurement of acute ...
John L, Sievenpiper +3 more
openaire +2 more sources
Addressing blinding in classic psychedelic studies with innovative active placebos [PDF]
International Journal of NeuropsychopharmacologyEmmanuelle Schindler +2 more
exaly +2 more sources
BMC Psychiatry, 2020 Background The issue of unblinded outcome-assessors and patients has repeatedly been stressed as a flaw in allegedly double-blind antidepressant trials. Unblinding bias can for example result from a drug‘s marked side effects.
Lisa Holper, Michael P. Hengartner
doaj +1 more source
A discursive exploration of public perspectives on placebos and their effects
Health Psychology Open, 2019 There is increasing evidence that placebos could be effective in clinical practice. However, knowledge of public perspectives on placebos is underdeveloped.
Doug I Hardman +4 more
doaj +1 more source
Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis. [PDF]
PLoS ONE, 2018 Several studies demonstrated that placebo treatment may have a significant impact on many different symptoms. While in the traditional view concealment of the placebo is essential, recent studies report intriguing evidence that placebos may work even ...
Michael Schaefer +2 more
doaj +1 more source
Placebo use in the United kingdom: results from a national survey of primary care practitioners.
PLoS ONE, 2013 ObjectivesSurveys in various countries suggest 17% to 80% of doctors prescribe 'placebos' in routine practice, but prevalence of placebo use in UK primary care is unknown.MethodsWe administered a web-based questionnaire to a representative sample of UK ...
Jeremy Howick +6 more
doaj +1 more source
Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials. [PDF]
PLoS ONE, 2015 Clinical trials use placebos with the assumption that they are inert, thus all placebos are considered to be equal. Here we show that this assumption is wrong and that different placebo procedures are associated to different therapeutic rituals which, in
Fabrizio Benedetti, Sara Dogue
doaj +1 more source